Argentina · Venture startup

Who invested in BioScience

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Manufacturing

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 2 rounds since 2011, from 2 sources

Latest round
Venture, $8.0MJan 2021
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201120132015201720192021
?Seed$8.0MVenture
First round
Seed
Mar 2011
Biggest round
$8.0M
Venture · Jan 2021
Between rounds
9.8 years
from the last two

The rounds

  1. Jan 2021
    Venture$8.0M1 new

    Source recorded

  2. Mar 2011
    SeedAmount undisclosed2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about BioScience

Who invested in BioScience?

BioScience's investors include Qiming Venture Partners, AxVentures-Pymar Fund and CAP Venture Capital.

How much has BioScience raised?

BioScience has raised $8.0M across 2 rounds since 2011. One round did not disclose an amount, so the total is a floor.

When did BioScience last raise?

BioScience's most recent round was a Venture of $8.0M in Jan 2021.

What was BioScience's biggest round?

Its most recent round, $8.0M in Jan 2021, is also its largest on record.

Who backed BioScience first?

BioScience's first round on record, in Mar 2011, was backed by AxVentures-Pymar Fund and CAP Venture Capital.

What stage is BioScience at?

BioScience's latest named round is a Venture, in Jan 2021.

Where is BioScience based?

BioScience is based in Argentina.

Companies like BioScience

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.